Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,805,862
-$188,631 QoQ
Shares Held
20,071
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#430
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. AZN ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,805,862 | 20,071 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $3,994,493 | 20,254 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||